Immunic, Inc. | WebDisclosure

Switch to English

8296	Sociétés
114902	Mots-clés
55328	Articles
62458	Communiqués

Accueil
Sociétés
Immunic, Inc.

COMMUNIQUÉ DE PRESSE

publié le 01/02/2024 à 12:30, il y a 9 mois 20 jours

Immunic to Participate in Investor and Scientific Conferences in February
Immunic, Inc. (Nasdaq: IMUX) to participate in BioCapital Europe 2024 and ACTRIMS Forum 2024 in February and March, presenting clinical pipeline therapies and poster presentations

Immunic, Inc. BioCapital Europe 2024 ACTRIMS Forum 2024 Clinical Pipeline Therapies Poster Presentations
COMMUNIQUÉ DE PRESSE

publié le 02/11/2023 à 11:30, il y a 1 année

Immunic Receives Notice of Allowance for United States Patent Protecting the Treatment of Relapsing Multiple Sclerosis with Vidofludimus and Its Salts
COMMUNIQUÉ DE PRESSE

publié le 26/10/2023 à 12:30, il y a 1 année

Immunic to Participate in Scientific and Industry Conferences in November
COMMUNIQUÉ DE PRESSE

publié le 16/10/2023 à 12:30, il y a 1 année 1 mois

Immunic Presents Data From Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Ulcerative Colitis at the United European Gastroenterology Week 2023
COMMUNIQUÉ DE PRESSE

publié le 15/10/2023 à 12:30, il y a 1 année 1 mois

Immunic Presents Data From Phase 1b Clinical Trial of IMU-856 in Celiac Disease at the United European Gastroenterology Week 2023
COMMUNIQUÉ DE PRESSE

publié le 11/10/2023 à 12:30, il y a 1 année 1 mois

Immunic Presents Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis at MSMilan2023: The 9th Joint ECTRIMS-ACTRIMS Meeting
COMMUNIQUÉ DE PRESSE

publié le 09/10/2023 à 22:01, il y a 1 année 1 mois

Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis
COMMUNIQUÉ DE PRESSE

publié le 04/10/2023 à 12:30, il y a 1 année 1 mois

Immunic to Participate in Scientific Conferences in October
COMMUNIQUÉ DE PRESSE

publié le 06/09/2023 à 12:30, il y a 1 année 2 mois

Immunic to Participate in Industry and Investor Conferences in September
COMMUNIQUÉ DE PRESSE

publié le 17/08/2023 à 12:30, il y a 1 année 3 mois

Immunic Completes Enrollment of Its Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis

Les Echos

Publié le 21/11/2024 à 06:58, il y a 6 heures 35 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 6 heures 35 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 6 heures 35 minutes

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 17 heures 26 minutes

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 18 heures 13 minutes

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 21/11/2024 à 13:00, il y a 33 minutes

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Publié le 21/11/2024 à 13:00, il y a 33 minutes

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Publié le 21/11/2024 à 13:00, il y a 33 minutes

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Publié le 21/11/2024 à 13:00, il y a 33 minutes

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Publié le 21/11/2024 à 13:00, il y a 33 minutes

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

Voir tout ACCESSWIRE

EQS Group

Publié le 21/11/2024 à 13:15, il y a 18 minutes

NOTICE OF ANNUAL GENERAL MEETING
Publié le 21/11/2024 à 12:35, il y a 58 minutes

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Publié le 21/11/2024 à 12:15, il y a 1 heure 18 minutes

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Publié le 21/11/2024 à 12:06, il y a 1 heure 27 minutes

IVU AG publishes Quarterly Report Q3-2024
Publié le 21/11/2024 à 12:00, il y a 1 heure 33 minutes

Holding(s) in Company